Skip to content

Clinical trials

Phase 2 Hip Fractures trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hip Fractures Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20071
20082
20091
20101
20143
20151
20172
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital for Special Surgery, New York3
Washington University School of Medicine2
Amgen1
Beth Israel Deaconess Medical Center1
Cartiva, Inc.1
Ian Elliott Brown1
Mayo Clinic1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Novartis Pharmaceuticals1
Rhode Island Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hip Fractures16
Atrophy1
Delirium1
Femoral Fractures1
Femoral Neck Fractures1
Femur Head Necrosis1
Fractures, Bone1
Inflammation1
Muscle Weakness1
Muscular Atrophy1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.